BGI’s human whole genome sequencing (WGS) service provides comprehensive coverage of an individual’s complete genome at a single time. WGS can be used to obtain a high-resolution, base-by-base view of the genome, capture both large and small variants that might otherwise be missed and identify potential causative variants for further follow-on studies of gene expression and regulation mechanisms.
At BGI, we have been providing commercial WGS services for over 10 years and have processed over 1,000,000 samples for partners across the world on our own DNBSEQ™ technology platforms. Our mission is to provide a fast and affordable service with industry leading data quality.
- Intact genomic DNA ≥ 1μg
- Concentration ≥ 12.5ng/ μl
- Volume 15 μl
Low Input Samples:
- Intact genomic DNA ≥ 200ng
- Concentration ≥ 2.5 ng/ μl
- Volume 15 μl
BGI Human Whole Genome Sequencing services are typically executed with our proprietary DNBSEQ™ NGS technology platform, for great sequencing data at the lowest cost in the industry.
DNBSEQ™ is a proprietary sequencing technology, first developed by BGI's Complete Genomics subsidiary in Silicon Valley, and can offer advantages in terms of lower amplification error rates and much lower duplication rates for some sequencing applications. In addition, studies have shown the index hopping rate in DNBSEQ™ platforms can be much lower when compared to that of other platforms.